DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Twelves C, Wong A, Nowacki M. et al.
Updated efficacy findings from the X-ACT phase III trial of capecitabine (X) vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with Dukes’ C colon cancer.
Proc Am Soc Clin Oncol 2005; Abstract: 3521-
We do not assume any responsibility for the contents of the web pages of other providers.